Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-01-01 @ 3:42 AM
Study NCT ID:
NCT05245669
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2022-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Sponsor:
Enzene Biosciences Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALK22/ENZ215-DEN1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |